<DOC>
	<DOCNO>NCT00171067</DOCNO>
	<brief_summary>The purpose study compare combination valsartan 320 mg/lisinopril 20 mg versus monotherapies lisinopril 40 mg valsartan 320 mg result great decrease urinary albumin excretion measure urinary albumin/creatinine ratio ( UACR ) first morning urine hypertensive subject previously diagnose microalbuminuria ( MAU ) .</brief_summary>
	<brief_title>VALERIA : Valsartan Combination With Lisinopril Hypertensive Patients With Microalbuminuria</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Patients mild moderate hypertension mean sit diastolic blood pressure ( MSDBP ) &gt; 85 &lt; 110 mmHg nontreated patient . Previously treat patient MSDBP &lt; 110 mmHg . Treated define take medication &lt; 2 day prior Visit 1 Positive urine spot test Micral dipstick ( detection urinary albumin concentration least 50 mg/l ) Visit 1 ( day 21 ) . Confirmation MAU least 2 3 measurement determine first morning urine sample perform Visit 1 day21 ) , Visit 2 ( day 14 ) Visit 3 ( day 7 ) . MAU define male patient urinary albumin creatinine ratio ( UACR ) &gt; 2.5 mg/mmol &lt; 25.0 mg/mmol female patient UACR &gt; 3.5 mg/mmol &lt; 35.0 mg/mmol visit . Evidence renal impairment determine one following : serum creatinine clearance &lt; 30 ml/min determine Cockroft Gault formula [ Cockroft Gault , 1976 ] and/or serum creatinine &gt; 1.25 x ULN Visit 1 , history dialysis , history nephrotic syndrome . Serum potassium value &lt; 3.5 mmol/l &gt; 5.5 mmol/l Visit 1 Any medical condition might significantly alter urinary excretion albumin Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Microalbuminuria , urinary albumin excretion , urinary albumin creatinine ratio , hypertension , valsartan , lisinopril , combination</keyword>
</DOC>